|
1. Biologie
|
|
|
|
3.1 Tabac
|
|
|
|
4.1 Dép., diag. & prono. - Prostate
|
|
|
|
Ben Stiller speaks about diagnosis with prostate cancer [The Guardian]
|
|
|
|
|
|
Stiller
writes: “If [the doctor] had waited, as the American Cancer Society
recommends, until I was 50, I would not have known I had a growing tumor
until two years after I got treated. If he had followed the US
Preventive Services Task Force guidelines, I would have never gotten
tested at all, and not have known I had cancer until it was way too late
to treat successfully.”
|
|
|
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
4.7 Dép., diag. & prono. - Col de l'utérus
|
|
|
|
5. Traitements
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
Precision Promise [PanCan]
|
|
|
|
|
|
Precision
Promise is the first large-scale precision medicine trial for patients
with pancreatic cancer, and it is the Pancreatic Cancer Action Network’s
groundbreaking initiative to advance our goal to double pancreatic
cancer survival by 2020.
|
|
|
|
|
|
|
5.12.1 Immunothérapies - partenariats
|
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
NICE rejects MSD’s Keytruda for lung cancer [Pharma Times]
|
|
|
|
|
|
The
company's submission assumed that patients stopped using Keytruda
(pembrolizumab) at two years if their disease had not progressed, but
the Institute's appraisal committee felt that in clinical practice "it
was very unlikely" that those benefiting from treatment would stop
taking it, and therefore it could not be considered value for money.
|
|
|
|
|
|
|
|
|
|
5.6 ESMO
|
|
|
|
ESMO 2016 Press Release: Impact of Cognitive Functions on Oral Cancer Therapies [ESMO]
|
|
|
|
|
|
Presented
at the ESMO Congress 2016, the results of a new study by Professor
Florence Joly and Dr Melanie Dos Santos of the Centre Francois Baclesse
in Caen, on the “Impact of cognitive functions on oral anticancer
therapies adherence” (1) highlights that cognitive disorders may be an
under-estimated major parameter (notably among elderly patients).
|
|
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.1 Observation
|
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
6.6 Publications
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
Megamerger finalized as ‘QuintilesIMS’ is born [FierceBiotech]
|
|
|
|
|
|
The
new company merges the real-world clinical applications of Quintiles’
business with IMS Health’s data gathering and analysis, as well as its
access to patient, prescription and other key healthcare data, giving
the new company a pool of information for drugmakers.
|
|
|
|
|
|
|
|